Palisade Bio Showcases Innovation at Upcoming Medical Conference
Palisade Bio, Inc. (Nasdaq: PALI), a pioneering clinical-stage biopharmaceutical company, has been honored with an opportunity to present its research at the esteemed Crohn’s & Colitis Congress. This congress is celebrated for gathering leading voices in the fields of autoimmune diseases, thereby fostering significant advancements in medical treatments.
Abstract Acceptance and Presentation Details
Recently, Palisade Bio received an exciting announcement regarding its abstract acceptance for a poster presentation scheduled for a specific time and date during the congress. This remarkable event, set to take place in San Francisco, will provide a platform for the company to present its innovative research findings directly to healthcare professionals, researchers, and key opinion leaders.
Details of the Poster Presentation
The details of the upcoming poster presentation include:
- Session: Poster and Exhibition Hall Reception
- Poster Title: PALI-2108, a Colon-Specific PDE4B Inhibitor Prodrug is Activated in the Colon and Reduces Ulcerative Colitis Symptoms in an Acute Colitis DSS Mouse Model
- Session Dates and Times: February 7, 2025 from 5:00 PM to 6:30 PM PST
- Presentation Location: Level 1 – Exhibition Hall – Moscone West
The Significance of the Crohn's & Colitis Congress
The Crohn’s & Colitis Congress is a pivotal event that gathers healthcare experts to discuss groundbreaking treatments and research innovations. It offers a unique environment for sharing knowledge, networking, and collaborative exploration of the latest advancements in the treatment of inflammatory bowel diseases (IBD).
Palisade Bio's Commitment to Innovation
Palisade Bio is at the forefront of biopharmaceutical innovation, devoted to developing targeted therapeutics that address the unique challenges faced by patients suffering from autoimmune, inflammatory, and fibrotic diseases. The company aims to transform the current treatment landscape by introducing effective and novel solutions.
Future Directions and Impact
As Palisade Bio prepares for its presentation, it continues to make strides in the research and development of therapies that can significantly improve patient outcomes. The company believes that attending significant events like the Crohn’s & Colitis Congress is crucial for fostering collaborations that might accelerate the advancements in treatment methodologies.
Getting Involved
For individuals eager to learn more about the congress and Palisade Bio's contribution to it, further information can be accessed through the congress's official channels. Engaging with the research community at such events can lead to partnerships that advance treatment options for those affected by chronic conditions.
About Palisade Bio
Palisade Bio is dedicated to developing novel therapeutics that demonstrate the potential to revolutionize treatment for patients coping with autoimmune and inflammatory diseases. The company’s focused approach signifies its commitment to enhancing quality of life through innovative solutions. For additional information about the company and its research endeavors, interested parties can visit www.palisadebio.com.
Investor Relations
The company encourages inquiries and is available to provide more insights into its milestones and strategic direction. Investor relations can be reached through:
- Contact: JTC Team, LLC
- Representative: Jenene Thomas
- Phone: 908-824-0775
- Email: PALI@jtcir.com
Frequently Asked Questions
What is the focus of Palisade Bio?
Palisade Bio specializes in developing therapeutics targeted at autoimmune, inflammatory, and fibrotic diseases.
When is the poster presentation scheduled?
The poster presentation is scheduled for February 7, 2025, from 5:00 PM to 6:30 PM PST.
Where will the congress be held?
The congress will take place in San Francisco, CA, specifically at the Moscone West exhibition hall.
What is the significance of the Crohn's & Colitis Congress?
This congress serves as an important platform for sharing research and fostering collaborations focused on inflammatory bowel diseases.
How can one get more information about Palisade Bio?
For further inquiries, visit Palisade Bio's official website or contact their investor relations.
